Combining and sequencing adjuvant chemotherapy and tamoxifen in postmenopausal women with node-positive breast cancer

Author： Leeper Alexander   Dixon J Michael  

Publisher： Future Medicine

ISSN： 1745-5057

Source： Women's Health, Vol.6, Iss.3, 2010-05, pp. : 357-360

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Adjuvant Tamoxifen Therapy on Thyroid Function in Postmenopausal Women with Breast Cancer

By  

Oncology, Vol. 56, Iss. 1, 1999-01 ,pp. : 43-45

Karger

Access to resources Recommend Favorite

CT‐Guided Wire Localization for Involved Axillary Lymph Nodes After Neo‐adjuvant Chemotherapy in Patients With Initially Node‐Positive Breast Cancer

By  

THE BREAST JOURNAL, Vol. 22, Iss. 4, 2016-07 ,pp. : 390-396

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomised Trial: One Cycle of Anthracycline-Containing Adjuvant Chemotherapy Compared with Six Cycles of CMF Treatment in Node-Positive, Hormone Receptor-Negative Breast Cancer Patients

By  

Oncology Research and Treatment, Vol. 26, Iss. 2, 2003-05 ,pp. : 115-119

Karger

Access to resources Recommend Favorite

Physical activity and survival of postmenopausal, hormone receptor–positive breast cancer patients: Results of the Tamoxifen Exemestane Adjuvant Multicenter Lifestyle study

By  

CANCER, Vol. 120, Iss. 18, 2014-09 ,pp. : 2847-2854

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost utility analysis of early adjuvant letrozole or anastrozole versus tamoxifen in postmenopausal women with early invasive breast cancer: the UK perspective

By Karnon Jonathan  

The European Journal of Health Economics, Vol. 9, Iss. 2, 2008-05 ,pp. : 171-183

Springer Publishing Company

Access to resources Recommend Favorite